Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1075809
Max Phase: Preclinical
Molecular Formula: C43H38N8O6
Molecular Weight: 762.83
Molecule Type: Small molecule
Associated Items:
ID: ALA1075809
Max Phase: Preclinical
Molecular Formula: C43H38N8O6
Molecular Weight: 762.83
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)c1coc(-c2ccccc2)n1)N[C@@H](Cc1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1)C(=O)O
Standard InChI: InChI=1S/C43H38N8O6/c52-38(24-45-39(53)35(21-33-23-44-27-46-33)49-40(54)37-26-57-41(50-37)29-13-5-1-6-14-29)48-36(42(55)56)22-34-25-51(28-47-34)43(30-15-7-2-8-16-30,31-17-9-3-10-18-31)32-19-11-4-12-20-32/h1-20,23,25-28,35-36H,21-22,24H2,(H,44,46)(H,45,53)(H,48,52)(H,49,54)(H,55,56)/t35-,36-/m0/s1
Standard InChI Key: FEZUJRMBAHUDQP-ZPGRZCPFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 762.83 | Molecular Weight (Monoisotopic): 762.2914 | AlogP: 4.37 | #Rotatable Bonds: 16 |
Polar Surface Area: 197.13 | Molecular Species: ACID | HBA: 9 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 14 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.46 | CX Basic pKa: 6.53 | CX LogP: 2.80 | CX LogD: 2.21 |
Aromatic Rings: 7 | Heavy Atoms: 57 | QED Weighted: 0.09 | Np Likeness Score: -0.41 |
1. Tan KT, Guiu-Rozas E, Bon RS, Guo Z, Delon C, Wetzel S, Arndt S, Alexandrov K, Waldmann H, Goody RS, Wu YW, Blankenfeldt W.. (2009) Design, synthesis, and characterization of peptide-based rab geranylgeranyl transferase inhibitors., 52 (24): [PMID:19894725] [10.1021/jm901117d] |
Source(1):